Board of directors

  • Allyson Kaye MBE, President

    Allyson lost her mother to ovarian cancer 30 years ago. Subsequently, Allyson has been involved in the field of ovarian cancer for 20 years and she founded Ovarian Cancer Action in 2005. She developed the first UK ovarian cancer national awareness campaign, which was instrumental in the start-up of the charity and the formal recognition of the symptoms of ovarian cancer in the UK today. In 2006 Ovarian Cancer Action opened its Research Centre at Imperial College where there are now more than 60 researchers. She is an active member on several science and cancer related boards and a driving force for the HHMT International Forum on Ovarian Cancer, where scientists debate and prioritise new directions in research and ways to accelerate progress. She is well-known to worldwide ovarian cancer researchers and is an author of several papers, including the latest roadmap for the future of ovarian cancer research and treatment, which was published in Nature Reviews Cancer. In the 2014 New Year’s Honours List Allyson was awarded an MBE for her work.

  • Dr Wayne Phillips, Chair

    Wayne founded Double Helix in 1995 after many years of senior and international roles within the pharmaceutical industry. A Physician with post graduate qualifications in pharmaceutical medicine, Wayne was chairman of the British Association of Pharmaceutical Physicians. He has expertise in clinical development, biostatistics, regulatory affairs and medical communications.

    Wayne has over 30 years' experience in the pharmaceutical industry, of which 16 years was in clinical development and medical marketing. Prior to founding Double Helix, Wayne was Medical Director, Genentech Europe, Switzerland, and was responsible for several clinical development teams in Europe. He was previously the UK and Ireland Medical Director for Sandoz Pharmaceuticals.

  • Emma Scott, Vice Chair

    For the past decade Emma has been a Non-Executive Director at Ovarian Cancer Action and chairs the Remuneration and Nomination and Fundraising Committees. 

    Emma is an award-winning CEO and experienced Non-Executive Director across public, private and not-for-profit sectors. She recently stepped down as CEO of Beano Studios where she transformed the comic brand to become a global entertainment business with a TV production company, digital and
    e-commerce platform and creative agency. Prior to that, Emma was CEO of Freesat, the digital satellite TV service, an ITV Plc and BBC joint venture. She previously launched Freeview and was Chief of Staff to BBC Director-General, Greg Dyke, leading major strategic initiatives for the corporation.
  • Nathalie Burdet

    Nathalie joined Kantar as CMO of the Insights Division in 2018. Prior to this Nathalie was Head of Marketing and Brand Strategy at NEX Group Plc (formerly ICAP), where she developed , launched and built the NEX brand globally (recently acquired by CME group). Nathalie worked previously for Fundtech, a Global Transaction Banking Solutions Business,  as Global Marketing Director. Nathalie also spent 8 years at Thomson Reuters in a variety of marketing and communications roles culminating in her being appointed Head of Marketing where she developed the internal marketing and communication strategy for Thomson Reuters flagship product Thomson Reuters Eikon. Nathalie also worked for over 4 years at Temenos, a global banking software provider, where she rebranded the company and launched Temenos T 24, their flagship product. She started her career working for a start up in London in 1998. Nathalie holds a LLM in European and international business law and a Postgraduate Diploma in Marketing from the Chartered Institute of Marketing in London.

  • Professor Richard Hunt

    Richard Hunt is Professor Emeritus of Medicine and Gastroenterology at McMaster University in Hamilton, Ontario, Canada and a faculty member of the Farncombe Family Digestive Health Research Institute. He is a Fellow of the Royal College of Physicians of London, Edinburgh and Canada, and American Gastroenterology Association. He is a Master of the American College of Gastroenterology and a Master of the World Gastroenterology Organization. Richard has been recognized with many prizes and medals for his work in Gastroenterology including the Gilbert Blane Medal and the Bockus Medal. Richard is currently a Director and Vice President of the Canadian Digestive Health Foundation of which he was also a founding member.

  • Jenny Knott

    Jenny's career in investment banking spans nearly 30 years and many geographies and cultures. Jenny was appointed Chief Executive Officer of the Post Trade Risk and Information division at ICAP in August 2015 and is a member of the GEMG. Jenny has previously worked with Standard Bank, developing the group's franchise and building sustainable relationships with clients, key stakeholders and the wider communities. Jenny won the award for Women in the City Woman of Achievement Financial Services 2011, and is a pioneer for Corporate and Social responsibility initiatives being treasurer/fundraiser/trustee/founder sponsor of many organisations.

  • Jane Wolfson

    Jane has over 20 years’ experience in the marketing and media industry. She joined the global media company Hearst in the UK in June 2015 as their Head of Commercial Operations, responsible for commercial delivery across Hearst’s portfolio of print and digital brands. Jane became Director of the content marketing division, Hearst Made, in September 2016. She is responsible for the growth strategy of the division, enhancing its profile and reputation across the industry, and building long term brand content partnerships with clients and agencies.

  • Professor Sir Nicholas Wright

    Sir Nicholas Alcwyn Wright is centre lead at the Centre for Tumour Biology, in the Barts Cancer Institute at Charterhouse Square, where his research concentrates on the development of gastrointestinal cancer. He was knighted in the New Year Honours list for 2006 for services to medicine.

  • Kirstie Hutchinson

    Kirstie is a solicitor and a partner in the Finance team at City law firm Macfarlanes LLP.  Her practice focuses on private equity sponsors, corporate borrowers, credit fund and bank lenders, special situations investors and speciality finance providers across a range of financing transactions.  She is recognised by Legal 500 UK 2019 as a ‘Leading Individual’ in Bank Lending: Investment Grade Debt and Syndicated Lending and as a ‘Next Generation Partner’ in Acquisition Finance; and by Chambers UK 2020 as an ‘Up and Coming’ partner in Banking & Finance by Chambers UK 2020.  Kirstie is a member of the British-German Jurists’ Association and of her Firm’s finance, international and diversity committees.  She is a partner champion of Macfarlanes’ LGBT & friends staff network, a forum for networking and peer support between LGBT staff and allies.  Kirstie lost her aunt to ovarian cancer in 2014 and joined the board of Ovarian Cancer Action in 2019.